- Home
- ENLV vs SHFS Comparison
ENLV vs SHFS Comparison
Compare ENLV & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- SHFS
- Stock Information
- Founded
- ENLV 2005
- SHFS 2015
- Country
- ENLV Israel
- SHFS United States
- Employees
- ENLV N/A
- SHFS N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- SHFS Finance: Consumer Services
- Sector
- ENLV Health Care
- SHFS Finance
- Exchange
- ENLV Nasdaq
- SHFS Nasdaq
- Market Cap
- ENLV 20.7M
- SHFS 20.8M
- IPO Year
- ENLV 1995
- SHFS N/A
- Fundamental
- Price
- ENLV $0.92
- SHFS $3.30
- Analyst Decision
- ENLV Strong Buy
- SHFS
- Analyst Count
- ENLV 2
- SHFS 0
- Target Price
- ENLV $10.00
- SHFS N/A
- AVG Volume (30 Days)
- ENLV 62.6K
- SHFS 2.3M
- Earning Date
- ENLV 06-13-2025
- SHFS 05-12-2025
- Dividend Yield
- ENLV N/A
- SHFS N/A
- EPS Growth
- ENLV N/A
- SHFS N/A
- EPS
- ENLV N/A
- SHFS N/A
- Revenue
- ENLV N/A
- SHFS $16,102,301.00
- Revenue This Year
- ENLV N/A
- SHFS N/A
- Revenue Next Year
- ENLV N/A
- SHFS N/A
- P/E Ratio
- ENLV N/A
- SHFS N/A
- Revenue Growth
- ENLV N/A
- SHFS N/A
- 52 Week Low
- ENLV $0.81
- SHFS $1.84
- 52 Week High
- ENLV $1.84
- SHFS $18.80
- Technical
- Relative Strength Index (RSI)
- ENLV 44.97
- SHFS 46.12
- Support Level
- ENLV $0.86
- SHFS $3.25
- Resistance Level
- ENLV $0.91
- SHFS $4.33
- Average True Range (ATR)
- ENLV 0.06
- SHFS 0.46
- MACD
- ENLV 0.00
- SHFS 0.27
- Stochastic Oscillator
- ENLV 47.06
- SHFS 58.68
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About SHFS SHF Holdings Inc.
SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.